Would you really have taken up your entitlement at a higher price than what you could have bought on market if you had received the documents in time?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025